Related Experiment Video
Updated: Jan 26, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
Identification of a lytic Pseudomonas aeruginosa phage depolymerase and its anti-biofilm effect and bactericidal
Liyuan Mi1, Yannan Liu2,3, Can Wang2
1Key Laboratory of Marine Drugs, Chinese Ministry of Education; Key Laboratory of Glycoscience & Glycotechnology of Shandong Province; School of Medicine and Pharmacy; Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Ocean University of China, 5 Yushan Road, Qingdao, 266003, China.
Abstract:
Pseudomonas aeruginosa (P. aeruginosa) infection has imposed a great threat to patients with cystic fibrosis. With the emergence of multidrug-resistant P. aeruginosa, developing an alternative anti-microbial strategy is indispensable and more urgent than ever. In this study, a lytic P. aeruginosa phage was isolated from the sewage of a hospital, and one protein was predicted as the depolymerase-like protein by genomic sequence analysis, it includes two catalytic regions, the Pectate lyase_3 super family and Glycosyl hydrolase_28 super family. Further analysis demonstrated that recombinant depolymerase-like protein degraded P. aeruginosa exopolysaccharide and enhanced bactericidal activity mediated by serum in vitro. Additionally, this protein disrupted host bacterial biofilms. All of these results showed that the phage-derived depolymerase-like protein has the potential to be developed into an anti-microbial agent that targets P. aeruginosa.
Insights
A novel phage protein effectively degrades Pseudomonas aeruginosa exopolysaccharides and disrupts biofilms. This finding offers a promising new strategy against multidrug-resistant bacterial infections.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Pseudomonas aeruginosa infections pose a significant threat, particularly to cystic fibrosis patients.
- The rise of multidrug-resistant strains necessitates urgent development of alternative antimicrobial strategies.
Purpose of the Study:
- To investigate a depolymerase-like protein derived from a Pseudomonas aeruginosa phage as a potential antimicrobial agent.
- To evaluate the protein's efficacy in degrading bacterial exopolysaccharides and disrupting biofilms.
Main Methods:
- Isolation of a lytic Pseudomonas aeruginosa phage from hospital sewage.
- Genomic analysis to identify and predict a depolymerase-like protein with two catalytic regions.
- Recombinant protein expression and in vitro assays to assess exopolysaccharide degradation and serum-mediated bactericidal activity.
- Evaluation of the protein's effect on bacterial biofilm disruption.
Main Results:
- The identified depolymerase-like protein possesses Pectate lyase_3 and Glycosyl hydrolase_28 superfamily catalytic regions.
- Recombinant protein successfully degraded Pseudomonas aeruginosa exopolysaccharides in vitro.
- The protein enhanced serum-mediated bactericidal activity against Pseudomonas aeruginosa.
- The depolymerase-like protein demonstrated the ability to disrupt bacterial biofilms.
Conclusions:
- The phage-derived depolymerase-like protein exhibits significant potential as a novel antimicrobial agent targeting Pseudomonas aeruginosa.
- This protein represents a promising therapeutic candidate for combating multidrug-resistant Pseudomonas aeruginosa infections.
Related Concept Videos
Lytic Cycle of Bacteriophages
Binet's Contribution to Measures of Intelligence
Viral Replication: Lytic Cycle
Biofilms
Wechsler's Contribution to Measures of Intelligence
Lysogenic Cycle of Bacteriophages

